Literature DB >> 28298069

Expression of VRK1 and the downstream gene BANF1 in esophageal cancer.

Jin Li1, Tingting Wang1, Lu Pei1, Junpeng Jing2, Wentan Hu1, Tiange Sun3, Hongchun Liu4.   

Abstract

Esophageal cancer is considered one of the most malignant tumors, being characterized by rapid progression and poor outcomes. China has the highest incidence of esophageal cancer in the world. Hence, it is necessary to clarify the mechanisms underlying esophageal cancer progression. In this study, we examined the expression of vaccinia-related kinase 1 (VRK1) and barrier to autointegration factor 1 (BANF1) in tumor tissues at the mRNA and protein levels via real-time PCR and immunohistochemical analyses. The mRNA and protein expression levels of VRK1 and BANF1 were higher in tumor tissues than in adjacent normal tissues. ROC curve analysis showed that VRK1 and BANF1 yielded AUCs of 0.790 and 0.735, respectively, for the detection of esophageal squamous cell carcinoma(ESCC) patients. In conclusion, our study indicates that VRK1 and BANF are promising novel therapeutic targets for esophageal cancer.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Barrier to autointegration factor 1 (BANF1); Esophageal cancer; Vaccinia-related kinase 1 (VRK1)

Mesh:

Substances:

Year:  2017        PMID: 28298069     DOI: 10.1016/j.biopha.2017.02.095

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

Review 1.  Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

Authors:  Graham F Brady; Raymond Kwan; Juliana Bragazzi Cunha; Jared S Elenbaas; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-03-13       Impact factor: 22.682

Review 2.  Diverse cellular functions of barrier-to-autointegration factor and its roles in disease.

Authors:  Rhiannon M Sears; Kyle J Roux
Journal:  J Cell Sci       Date:  2020-08-17       Impact factor: 5.285

3.  Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma.

Authors:  Joëlle S Nader; Jérôme Abadie; Sophie Deshayes; Alice Boissard; Stéphanie Blandin; Christophe Blanquart; Nicolas Boisgerault; Olivier Coqueret; Catherine Guette; Marc Grégoire; Daniel L Pouliquen
Journal:  Oncotarget       Date:  2018-03-27

Review 4.  Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?

Authors:  Ignacio Campillo-Marcos; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2018-04-20       Impact factor: 9.261

5.  Downregulation of VRK1 reduces the expression of BANF1 and suppresses the proliferative and migratory activity of esophageal cancer cells.

Authors:  Zhenzhen Ren; Jie Geng; Chao Xiong; Xuebing Li; Yuqing Li; Jin Li; Hongchun Liu
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

6.  Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer.

Authors:  Junjun Li; Bingbing Hu; Lei Fang; Yang Gao; Shuai Shi; Haoyu He; Xiaomei Liu; Caijun Yuan
Journal:  Oncol Lett       Date:  2018-09-11       Impact factor: 2.967

7.  Expression and Prognostic Significance of BANF1 in Triple-Negative Breast Cancer.

Authors:  Genhao Zhang
Journal:  Cancer Manag Res       Date:  2020-01-08       Impact factor: 3.989

8.  DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.

Authors:  Rebeca Carrión-Marchante; Valerio Frezza; Ana Salgado-Figueroa; M Isabel Pérez-Morgado; M Elena Martín; Víctor M González
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

9.  VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.

Authors:  Zhen-Chuan Liu; Kuo Cao; Zhao-Hua Xiao; Liang Qiao; Xue-Qing Wang; Bin Shang; Yang Jia; Zhou Wang
Journal:  Oncotarget       Date:  2017-08-07

10.  Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.

Authors:  Saioa Mendaza; Joaquín Fernández-Irigoyen; Enrique Santamaría; Tamara Zudaire; Rosa Guarch; David Guerrero-Setas; August Vidal; José Santos-Salas; Xavier Matias-Guiu; Karina Ausín; María José Díaz de Cerio; Esperanza Martín-Sánchez
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.